外细胞腺在急性压力诱导的类似抑郁的行为:它来自哪里?
Cui-Yuan Chen1, Xin-Ran Yang1, Meng Wang1
1International Collaborative Center on Big Science Plan for Purine Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu, China; School of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Neuropharmacology
|October 24, 2025
概括
急性压力会增加海马体内的细胞外腺,导致类似抑郁的行为. 不同的压力类型激活不同的腺路径,为主要抑郁症 (MDD) 提供潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 精神病学是一个精神病学.
背景情况:
- 重度抑郁症 (MDD) 是一种常见的精神疾病,具有复杂的神经化学基础.
- 了解压力引起的神经化学变化对于开发有效的抑郁症治疗至关重要.
研究的目的:
- 在急性压力期间,研究细胞外腺在腹部海马体CA1区域的来源和功能.
- 探索纯能信号在压力诱导的抑郁类行为中的作用.
主要方法:
- 在小鼠中使用了GRAB光传感器 (GRABATP1.0,GRABAdo1.0) 的纤维光度计,以实时监测腺和ATP动态.
- 使用尾部悬挂试验 (TST) 和足部冲击 (FS) 作为急性应力范式.
- 使用药理封锁来识别腺源和评估行为结果.
主要成果:
- 无论是TST还是FS,都在CA1区域显著提高了细胞外腺水平.
- 足震 (FS) 独特地增加了细胞外ATP水平.
- 由TST诱导的腺主要来自ENT1/2运输,而由FS衍生的腺则涉及ENT1/2和CD73通路.
- 这些途径的抑制改善了FS诱导的抑郁表型.
- 外源ATP或腺的使用加剧了类似抑郁症的行为.
结论:
- 腹部海马体中的细胞外腺的不同来源有助于急性压力诱导的类似抑郁的行为.
- 这项研究阐明了纯能信号在应激反应中的作用.
- 这些发现可能有助于开发针对情绪障碍的新型治疗策略.
相关概念视频
Hypothalamic-Pituitary Axis
65.4K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.4K
Physiological Foundation of Stress
553
Stress triggers a coordinated physiological response involving the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis. This dual activation ensures that the body is prepared for both immediate and prolonged stress management. The process begins with the perception of a stressor. This initial phase activates the SNS, leading to the rapid release of adrenaline (epinephrine) from the adrenal glands.
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Role of the Sympathetic Nervous System
Adrenaline triggers the...
553
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Adrenergic Neurons: Neurotransmission
5.1K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.1K
Adrenergic Agonists: Indirect-Acting Agents
2.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.6K
Depressive Disorders: Etiology
437
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
437


